Breaking News

AMRI Resumes Albuquerque Ops

Completes remediation following an environmental deviation

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI’s Albuquerque, NM sterile injectable facility has resumed full manufacturing operations. The company has completed remediation following an environmental deviation in one manufacturing suite as a result of a weather related business interruption this past September.    AMRI’s OsoBio facility, acquired in July 2014, provides cGMP manufacturing and sterile filling of parenteral drugs using specialized technologies, including lyophilization. OsoBio also supports commercial scale producti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters